Flu Vaccination Extended Amid High Influenza Activity in France

As flu activity remains high, health authorities have extended the vaccination campaign by an additional month, aiming to curb the persistent spread of the virus and protect vulnerable populations amid ongoing intense transmission.

Widespread Flu Activity Raises Concerns

This winter, the spread of the influenza virus in France has prompted renewed vigilance, despite recent data suggesting a slight dip in medical consultations across all age brackets. The latest update from Santé Publique France, released on January 28, 2026, underlines that the situation remains “very active.” While some health experts cautiously observe signs of a plateau, anxiety lingers—particularly for those most susceptible to severe forms of the illness.

Vaccination Uptake Falls Short of Expectations

Efforts to blunt the impact of this year’s flu season have faced considerable obstacles. Figures compiled as of December 31, 2025 reveal that only 46.3% of at-risk groups have received the flu shot so far. While vaccination rates among people over 65 years old have inched up to 53.3%, this modest improvement hardly matches the urgency posed by such a virulent season. Coverage among adults under 65 with chronic conditions or other risk factors remains troublingly low.

Several factors explain this ongoing challenge:

• Lack of awareness among certain high-risk populations.
• Mistrust or skepticism about vaccine efficacy and necessity.
• Complacency as case numbers begin to stabilize.

Extended Campaign and Priority Groups

In response, the Direction générale de la Santé took decisive action on January 27 by prolonging the nationwide vaccination campaign until February 28. The goal: offer an extra layer of protection to the most vulnerable citizens. The current influenza vaccine shows an estimated effectiveness of 36.5% across all ages—a figure that may seem modest but is still critical in preventing severe complications.

Who stands to benefit most from this extension? Recommendations strongly target:
– Seniors aged 65 and older,
– Individuals suffering from chronic illnesses or obesity,
– Pregnant women and families with frail infants,
– Health professionals regularly exposed to infection risks.

The vaccine is widely available throughout France and fully reimbursed by Assurance-maladie. Administration is possible through doctors, nurses, midwives, and pharmacists—a network designed for easy access.

The Ongoing Importance of Preventive Measures

Nonetheless, immunization alone will not suffice to curb viral transmission. Authorities continue to stress the value of daily barrier gestures: mask-wearing when symptomatic or in crowded places, frequent hand washing with sanitizer after touching shared surfaces, and regular ventilation of indoor spaces. These practices serve as essential complements to vaccination efforts—especially as health officials urge persistent caution for vulnerable populations during these final winter weeks.

While hopes rise that another epidemic surge is unlikely, public health leaders warn that lowering one’s guard too soon would be premature—especially for those most at risk.